Purun Cheong

Cravath Swaine & Moore / UNITED STATES


3

analized transaction

1250 Eur. ML

aggregated deals value

Last 12 months dossier

3

analized transaction

1250 Eur. ML

aggregated deals value

Full dossier

Client portfolio

PBV Rating


provides a qualitative rating based on Partner's clients feedback assessment

Communication Skills

The indicator measures the ability to convey information to another effectively and efficiently.

FusionCharts will load here.

Technical skills

The indicator measures knowledge of, and skill in the exercise of, practices required for successful accomplishment of a business, job, or task.

FusionCharts will load here.

Efficiency

The indicator measures the comparison of what is actually performed with what can be achieved with the same consumption of resources.

FusionCharts will load here.


Effectiveness

The indicator measures the degree to which objectives are achieved and the extent to which targeted problems are solved.

FusionCharts will load here.



Perceived Added Value

The indicator measures the evaluation of the difference between the cost of the tax / legal counsel and the contribution of the professional to achieve the business objectives of the matter.

FusionCharts will load here.

Market position

FusionCharts XT will load here!

News

  • 12/6/2018
  • EN

    Leggett & Platt's $1.25 Billion Acquisition of Elite Comfort Solutions

    Cravath is representing JPMorgan Chase Bank, N.A. in connection with the arrangement of $900 million of credit facilities that will be made available to Leggett & Platt in order to finance the acquisition.
  • 11/30/2018
  • EN

    SurveyMonkey's $295 Million Second Amended and Restated Credit Facilities

    Cravath represented JPMorgan Chase Bank, N.A., as administrative agent and lead arranger, in connection with the arrangement of $295 million second amended and restated credit facilities made available to SurveyMonkey Inc.
  • 9/15/2018
  • EN

    HLS Therapeutics' $125 Million Credit Facilities

    Cravath represented the borrower, HLS Therapeutics Inc., in connection with the arrangement of its $125 million credit facilities provided by JPMorgan Chase Bank, N.A., to be used for working capital and other general corporate purposes.

Results are based upon public information and may undervalue a law firm's and/or a lawyer's professional experience and client portfolio.